Success of weight loss medication in the UK
The Success of Weight Loss Medications in the UK: A Focus on Wegovy and Mounjaro In recent years, the rise of obesity and related health issues has prompted a surge in the development and use of weight loss medications. Among these, Wegovy and Mounjaro have emerged as leading options in the UK, each offering unique mechanisms and results. This blog explores the efficacy, safety, and overall success of these medications, providing insights for those considering them for weight management. Understanding Wegovy and Mounjaro Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist specifically approved for weight management. It functions by mimicking hormones that regulate appetite, leading to reduced caloric intake. Clinical trials indicate that individuals using Wegovy can expect an average weight loss of about 15% over a year, with approximately 69% of participants achieving over 10% weight loss12. Conversely, Mounjaro (tirzepatide) was initially developed for type 2...